| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/21/1991 | WO1991002005A1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides |
| 02/21/1991 | WO1991002004A1 IMMUNOGENIC GLYCOPROTEINS OF HUMAN CYTOMEGALOVIRUS gCII |
| 02/21/1991 | WO1991002003A1 Methods and compositions; purified preparation of neural progenitor regulatory factor |
| 02/21/1991 | WO1991002001A1 A megakaryocytopoietic factor |
| 02/21/1991 | WO1991001999A1 Phospholipase a2 inhibiting protein originating in inflamed region, production thereof, and gene therefor |
| 02/21/1991 | WO1991001976A1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same |
| 02/21/1991 | WO1991001760A1 Human tumor cells implanted in non-human animals |
| 02/21/1991 | WO1991001754A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 02/21/1991 | WO1991001746A1 Thy-1 receptor and its use for regenerating nerve cell processes |
| 02/21/1991 | WO1991001745A1 Growth factors containing vitamin a or other retinoids and uses thereof |
| 02/21/1991 | WO1991001744A2 Uses of interleukin-4 and method for purifying it |
| 02/21/1991 | WO1991001743A1 Stabilized protein or peptide conjugates |
| 02/21/1991 | DE3927449A1 New insulin fusion proteins |
| 02/21/1991 | DE3927139A1 Extraction and purificn. of ferritin - using protease from biological material to degrade contaminating proteins without degrading ferritin |
| 02/21/1991 | CA2064753A1 Uses of interleukin-4 and method for purifying it |
| 02/21/1991 | CA2064738A1 Megakaryocytopoietic factor |
| 02/21/1991 | CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/20/1991 | EP0413622A1 Albumin derivatives with therapeutic functions |
| 02/20/1991 | EP0413421A1 Monellin analog and sweetening composition containing it |
| 02/20/1991 | EP0413383A1 Mutants of human interleukin-3 |
| 02/20/1991 | EP0413378A1 Escherichia coli vaccine |
| 02/20/1991 | EP0413209A1 LHRH analogs |
| 02/20/1991 | EP0413024A1 Protein having activity of inhibiting inflammation-inducing phospholipase a2 |
| 02/20/1991 | EP0413019A1 Synthetic plant genes and method for preparation |
| 02/19/1991 | WO1991002794A1 Nucleic acid fragments and diagnostic reagents derived from the hhv6/sie genome and procedures for diagnosing hhv6 infections |
| 02/19/1991 | WO1991002755A1 Fibulin |
| 02/19/1991 | WO1991002750A1 Novel inhibitors of thrombin |
| 02/19/1991 | WO1991002704A1 Ferritin analogs |
| 02/19/1991 | US4994565 Nucleotide sequence of gene specifically expressed by insulinoma |
| 02/19/1991 | US4994559 Human basic fibroblast growth factor |
| 02/19/1991 | US4994556 Antitumor agents |
| 02/19/1991 | US4994555 Process for recovery of glycopeptidic antibiotics |
| 02/19/1991 | US4994553 Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies |
| 02/19/1991 | US4994441 Kappa-caseino-glycopeptides or desialylated derivatives |
| 02/19/1991 | US4994438 For retention of coagulation activity in antihemophilic factor; deactivation of microorganisms |
| 02/19/1991 | US4994379 Modified signal peptides |
| 02/19/1991 | US4994369 T-cell activation related gene |
| 02/19/1991 | CA2064818A1 Fibulin |
| 02/19/1991 | CA2064069A1 Ferritin analogs |
| 02/19/1991 | CA2039159A1 Nucleic acide fragments and derivated diagnosis reactives from the hhv6/sie genome, and diagnosis process for hhv6 infections |
| 02/19/1991 | CA2023521A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 02/19/1991 | CA1280379C Peptides and compositions |
| 02/19/1991 | CA1280365C Radionuclide antibody coupling |
| 02/19/1991 | CA1280363C Peptide composition and method for the detection of antibodies to htlv-iii |
| 02/18/1991 | WO1991002795A1 Mutant pseudorabies virus, and vaccines containing the same |
| 02/18/1991 | CA2065002A1 Mutant pseudorabies virus, and vaccines containing the same |
| 02/17/1991 | CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/16/1991 | CA2023250A1 Cleavage site blocking antibody to prohormone proteins and uses thereof |
| 02/15/1991 | WO1991002800A1 Thylakoid targeting sequence |
| 02/15/1991 | CA2064903A1 Thylakoid targeting sequence |
| 02/14/1991 | DE3925876A1 Analysing lipoprotein(s) in whole serum by size fractionation - on agarose gel, then direct cholesterol assay of the individual fractions |
| 02/13/1991 | EP0412951A1 Peptides blocking cell attachment to S-laminin |
| 02/13/1991 | EP0412912A1 Transgenic plants of the species cucumis melo |
| 02/13/1991 | EP0412911A1 Plants with modified flowers |
| 02/13/1991 | EP0412841A1 Human thrombomodulin derivatives |
| 02/13/1991 | EP0412766A1 Peptide fragments of HIV |
| 02/13/1991 | EP0412762A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 02/13/1991 | EP0412557A1 Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor |
| 02/13/1991 | EP0412526A2 Expression vector for hirudin, hirudin fusion protein, transformed microorganism, and method for production of hirudin |
| 02/13/1991 | EP0412508A1 Analogues of vasopressin, their preparation and pharmaceutical use |
| 02/13/1991 | EP0412486A1 Antibodies to TNF binding protein I and F (ab) fragments thereof |
| 02/13/1991 | EP0412466A2 Preparation of a stable factor VIII |
| 02/13/1991 | EP0412465A1 Process for correct biocatalytic chain folding of denaturated recombinant fusion proteins |
| 02/13/1991 | EP0412350A2 Renininhibitors, procedure for their preparation and use as medicaments |
| 02/13/1991 | EP0412115A1 Hybrid peptides and methods of their use |
| 02/13/1991 | EP0412105A1 Stem cell inhibitors |
| 02/13/1991 | CN1049166A Substitution analogues of magainin peptides |
| 02/13/1991 | CN1049164A Aminooligohydroxy derivatives for inhibiting renin and process for preparing same |
| 02/13/1991 | CN1049106A Stabilized fgf composition and production thereof |
| 02/12/1991 | WO1991001739A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 02/12/1991 | US4992531 Production of proteins in active forms |
| 02/12/1991 | US4992530 Treatment of calcium metabolic disorders, cardiac disease and ulcers |
| 02/12/1991 | US4992420 Dental anti-plaque and anti-caries agent |
| 02/12/1991 | US4992418 Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin |
| 02/12/1991 | US4992417 Superactive human insulin analogues |
| 02/12/1991 | US4992378 C-DNA encoding human prolactin receptor |
| 02/12/1991 | US4992369 Fermentation process for glycopeptide antibiotic |
| 02/12/1991 | US4992367 Genetic engineering |
| 02/12/1991 | US4992364 Probe for DNA and a process for the detection of "Shigellae" and entero-invasive strains of Escherichia coli |
| 02/12/1991 | US4992273 Monoclonal antibodies secreted by hybridomas inhibits parasitic infections |
| 02/12/1991 | US4992271 Formulation for lipophilic IL-2 proteins |
| 02/12/1991 | US4992178 Inorganic ultrafiltration of microfiltration membrane modified by a hydrophilic polymer, its preparation process and its use for the separation of proteins |
| 02/12/1991 | US4992051 Containing deletion or insertion mutations; produce no antigen polypeptides |
| 02/12/1991 | CA2064787A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 02/12/1991 | CA2022983A1 Expression of a functional insect specific toxin gene in mammalian cells |
| 02/12/1991 | CA2022713A1 Human thrombomodulin derivatives |
| 02/12/1991 | CA2021880A1 Psycho-pharmacological peptides |
| 02/12/1991 | CA1280072C Antigens related to the aids virus glycoprotein envelope, especially precursors of this glycoprotein, methods for obtaining theses antigens and measures applied in these methods, applications of these antigens to the preparation of immunogen compositions or for the diagnosis of aids or related conditions |
| 02/10/1991 | WO1991001996A1 Peptide fragments of hiv |
| 02/10/1991 | CA2064691A1 Peptide fragments of hiv |
| 02/10/1991 | CA2021059A1 Process for encapsulation of biologicals |
| 02/09/1991 | CA2022816A1 Compounds |
| 02/07/1991 | WO1991001393A1 Artificial biological membrane |
| 02/07/1991 | WO1991001380A1 Monoclonal antibodies directed against proteins involved in plaquettary functions, their applications as diagnostic and therapeutic agents |
| 02/07/1991 | WO1991001379A1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 02/07/1991 | WO1991001376A1 Antigenic protein specific for blood-propagated non-a non-b hepatitis, dna wich codes for said protein, and method of producing said protein |
| 02/07/1991 | WO1991001375A1 Dna constructs, cells and plants derived therefrom |
| 02/07/1991 | WO1991001373A1 Fruit-specific transcriptional factors |
| 02/07/1991 | WO1991001334A1 A purified, human autoregulatory cytokine, compositions containing same and uses thereof |
| 02/07/1991 | WO1991001327A1 Peptides containing diamino-glycols as transition-state mimics |